Unknown

Dataset Information

0

Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy.


ABSTRACT: A major drawback with current cancer therapy is the prevalence of unrequired dose-limiting toxicity to non-cancerous tissues and organs, which is further compounded by a limited ability to rapidly and easily monitor drug delivery, pharmacodynamics and therapeutic response. In this report, the design and characterization of novel multifunctional "theranostic" nanoparticles (TNPs) is described for enzyme-specific drug activation at tumor sites and simultaneous in vivo magnetic resonance imaging (MRI) of drug delivery. TNPs are synthesized by conjugation of FDA-approved iron oxide nanoparticles ferumoxytol to an MMP-activatable peptide conjugate of azademethylcolchicine (ICT), creating CLIO-ICTs (TNPs). Significant cell death is observed in TNP-treated MMP-14 positive MMTV-PyMT breast cancer cells in vitro, but not MMP-14 negative fibroblasts or cells treated with ferumoxytol alone. Intravenous administration of TNPs to MMTV-PyMT tumor-bearing mice and subsequent MRI demonstrates significant tumor selective accumulation of the TNP, an observation confirmed by histopathology. Treatment with CLIO-ICTs induces a significant antitumor effect and tumor necrosis, a response not observed with ferumoxytol. Furthermore, no toxicity or cell death is observed in normal tissues following treatment with CLIO-ICTs, ICT, or ferumoxytol. These findings demonstrate proof of concept for a new nanotemplate that integrates tumor specificity, drug delivery and in vivo imaging into a single TNP entity through attachment of enzyme-activated prodrugs onto magnetic nanoparticles. This novel approach holds the potential to significantly improve targeted cancer therapies, and ultimately enable personalized therapy regimens.

SUBMITTER: Ansari C 

PROVIDER: S-EPMC3946335 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy.

Ansari Celina C   Tikhomirov Grigory A GA   Hong Su Hyun SH   Falconer Robert A RA   Loadman Paul M PM   Gill Jason H JH   Castaneda Rosalinda R   Hazard Florette K FK   Tong Ling L   Lenkov Olga D OD   Felsher Dean W DW   Rao Jianghong J   Daldrup-Link Heike E HE  

Small (Weinheim an der Bergstrasse, Germany) 20130827 3


A major drawback with current cancer therapy is the prevalence of unrequired dose-limiting toxicity to non-cancerous tissues and organs, which is further compounded by a limited ability to rapidly and easily monitor drug delivery, pharmacodynamics and therapeutic response. In this report, the design and characterization of novel multifunctional "theranostic" nanoparticles (TNPs) is described for enzyme-specific drug activation at tumor sites and simultaneous in vivo magnetic resonance imaging (M  ...[more]

Similar Datasets

| S-EPMC2933508 | biostudies-literature
| S-EPMC5144490 | biostudies-literature
| S-EPMC5605405 | biostudies-literature
| S-EPMC3057065 | biostudies-literature
| S-EPMC2821739 | biostudies-literature
| S-EPMC7692372 | biostudies-literature
| S-EPMC6339703 | biostudies-literature
| S-EPMC6321593 | biostudies-literature
| S-EPMC2637824 | biostudies-literature
| S-EPMC9571674 | biostudies-literature